Cardiometabolic Disease

Low education was able to predict incident CVD among patients who were initially healthy and CVD mortality among those with prevalent cardiometabolic disease, according to a study published in the European Heart Journal.

Soluble lectin-like oxidized LDL receptor-1, or sLOX-1, was elevated in psoriasis and associated with lipid-rich noncalcified coronary burden independent of hyperlipidemia status, according to results published in JAMA Dermatology.

Endocrine Today has compiled a list of the top five news reports posted from the Cardiometabolic Health Congress, held from Oct. 10 to 13 in Chicago.

CHICAGO — Patients with metabolic syndrome are at risk for developing HF with preserved ejection fraction, although the mechanisms behind this risk are speculative at the moment, according to a presentation at the Cardiometabolic Health Congress.

CHICAGO — Healio presents live updates from the late-breaking trials session at the Cardiometabolic Health Congress.

CHICAGO — GLP-1 receptor agonists are a medication class that has exhibited many benefits, especially in the cardiovascular realm, since being introduced, and more recent evidence has only solidified this notion, but the mechanisms behind their success are still difficult to pin down, according to a speaker at the Cardiometabolic Health Congress.

CHICAGO — In this video exclusive, Elizabeth McNally, MD, PhD, cardiologist and director of the Center for Genetic Medicine at Northwestern University, discusses implications of straight-to-consumer genetic testing, the subject of her presentation at the Cardiometabolic Health Congress.

Experts across the spectrum of cardiovascular disease, diabetes and obesity will come together for the 14th annual Cardiometabolic Health Congress to discuss evolving science and clinical practice advances in the prevention and management of cardiometabolic diseases.

In its 14th year, the Cardiometabolic Health Congress, taking place in Chicago from Oct. 10 to 13, will feature an extensive agenda including an innovative preconference summit, a broad variety of session topics, numerous advanced learning workshops and a faculty panel consisting of many of cardiometabolic medicine’s foremost clinical experts.

Combined, diabetes, obesity and insulin resistance are the most common cause of preventable death in the United States, responsible for millions of deaths and more than $600 billion in health care costs. The Cardiometabolic Health Congress, the largest U.S.-based multidisciplinary conference centered on the management and prevention of CV and metabolic disease, is being held October 10 to 13 in Chicago for health care practitioners committed to joining the fight against cardiometabolic disease.